Mylan’s Challenge To Constipation Treatment Is Deficient, Patent Owner Says
ALEXANDRIA, Va. — Bausch Health Ireland Ltd. on June 12 defended technology used in its constipation drug Trulance® as nonobvious, in a response filed with the Patent Trial and Appeal Board....To view the full article, register now.
Already a subscriber? Click here to view full article